Capital Fund Management (CFM)’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-18,644
| Closed | -$792K | – | 957 |
|
|
2020
Q3 | $792K | Sell |
18,644
-29,728
| -61% | -$1.26M | 0.01% | 419 |
|
|
2020
Q2 | $2.32M | Sell |
48,372
-28,138
| -37% | -$1.35M | 0.04% | 181 |
|
|
2020
Q1 | $3.52M | Buy |
76,510
+28,016
| +58% | +$1.29M | 0.05% | 187 |
|
|
2019
Q4 | $2.91M | Buy |
48,494
+36,459
| +303% | +$2.19M | 0.02% | 311 |
|
|
2019
Q3 | $681K | Buy |
+12,035
| New | +$681K | 0.01% | 494 |
|
|
2018
Q2 | – | Sell |
-14,258
| Closed | -$751K | – | 1288 |
|
|
2018
Q1 | $751K | Sell |
14,258
-34,589
| -71% | -$1.82M | ﹤0.01% | 615 |
|
|
2017
Q4 | $2.61M | Sell |
48,847
-76,683
| -61% | -$4.1M | 0.01% | 412 |
|
|
2017
Q3 | $7.49M | Buy |
125,530
+66,284
| +112% | +$3.95M | 0.05% | 213 |
|
|
2017
Q2 | $4.67M | Buy |
59,246
+9,900
| +20% | +$781K | 0.04% | 268 |
|
|
2017
Q1 | $4.09M | Buy |
+49,346
| New | +$4.09M | 0.03% | 331 |
|
|
2016
Q4 | – | Sell |
-82,415
| Closed | -$5.77M | – | 1156 |
|
|
2016
Q3 | $5.77M | Buy |
+82,415
| New | +$5.77M | 0.05% | 229 |
|